Aveanna Healthcare Holdings, Inc.AVAH

Aveanna Healthcare Holdings Inc. is a home health care provider that sells its wares under three shiny brand names-Home Health Care, Hospice Care, and Private Duty Nursing-each of which sounds like a service you’d want if you or your child needed round-the-clock attention. The company’s website and blog are full of smiling faces, warm testimonials, and a registered trademark heart logo, all of which are designed to reassure families that they are in capable, compassionate hands. The reality, as filed in the company’s 10-Q for the quarter ended 2 April 2026, is a bit less soothing: revenue of $647.9 million came with a net profit of just $41.7 million, and operating income of $69.3 million. That’s the kind of margin you’d expect from a business that’s either extremely efficient or extremely lucky, and the cash flow statement suggests it’s more the latter.

The company’s balance sheet is a study in contrasts: $2.02 billion in assets face $1.78 billion in liabilities, leaving a shareholders’ equity of $240.1 million. Cash and cash equivalents sat at $189.3 million, while operating cash flow for the quarter was a meagre $4.3 million. The diluted earnings per share of $0.19 and a diluted share count of 222.1 million shares tell a story of dilution as a primary capital strategy. The company’s Private Duty Nursing page promises ‘compassionate care’ and ‘privilege and honour,’ but the filings are silent on the cost of delivering that care in a labour-constrained, Medicaid-reimbursement world.

The company’s most recent public filing, a 10-Q for the quarter ended 2 April 2026, reports revenue from contracts with customers (excluding assessed tax) of $647.9 million, net income attributable to the parent of $41.7 million, operating income of $69.3 million, assets of $2.02 billion, liabilities of $1.78 billion, and stockholders’ equity of $240.1 million. Cash and cash equivalents were $189.3 million, net cash provided by operating activities was $4.3 million, and diluted earnings per share were $0.19 on a weighted average diluted share count of 222.1 million shares. The company’s locations page confirms a presence in 30 states, and its Private Duty Nursing page describes the service as ‘a privilege and an honour,’ though the filings do not quantify the privilege in dollars.

If you’re looking for a chart to stare at, the company’s SEC filings are the place to start, not the TradingView terminal. The evidence does not supply a share price, trading volume, or any market data beyond the filed financials. The company’s investor-relations rail is thin, and the most recent 8-Ks are ownership disclosures rather than operational updates. The only concrete development named in the evidence is the 2 June 2026 press release announcing the completion of the acquisition of Family First Homecare and the addition of $70 million in annual revenue guidance for fiscal 2026. The filing does not disclose the purchase price, integration costs, or the expected impact on cash flow, leaving investors to guess how much of that $70 million will ever hit the bank.

The company’s blog and website are full of human stories-Tyler the clinical supervisor in Wexford, Pennsylvania, for example-but the filings are quieter about the financial heart surgery required to keep those stories alive. The company’s locations page notes that Aveanna ‘may contact caregivers, patients, and patients’ parents or legal guardians via SMS/text message,’ which is either a convenience or an intrusion depending on your view of automated outreach. The evidence does not supply subscriber counts, opt-in rates, or the cost of those text campaigns.

The company’s filings are a reminder that home health care is a people business, not a platform business. The polished language on the website-‘highest quality care,’ ‘compassionate care,’ ‘privilege and honour’-does not change the fact that the company’s operating cash flow for the quarter was $4.3 million on $647.9 million in revenue. The gap between the brand story and the balance sheet is the story, and the evidence does not supply a bridge.